Related Experiment Videos
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma
M Abou-Shady1, H U Baer, H Friess
1Department of Visceral and Transplantation Surgery, University of Bern, Switzerland.
Background:
Transforming growth factor betas (TGF-betas) are multifunctional polypeptides that have been suggested to influence tumor growth. They mediate their functions via specific cell surface receptors (type I ALK5 and type II TGF-beta receptors). The aim of this study was to analyze the roles of the three TGF-betas and their signaling receptors in human hepatocellular carcinoma (HCC).
Methods:
HCC tissue samples were obtained from 18 patients undergoing partial liver resection. Normal liver tissues from 7 females and 3 males served as controls. The tissues for histological analysis were fixed in Bouin's solution and paraffin embedded. For RNA analysis, freshly obtained tissue samples were snap frozen in liquid nitrogen and stored at -80 degrees C until used. Northern blot analysis was used in normal liver and HCC to examine the expression of TGF-beta1, -beta2, -beta3 and their receptors: type I ALK5 (TbetaR-I ALK5), type II (TbetaR-II), and type III (TbetaR-III). Immunohistochemistry was performed to localize the corresponding proteins.
Results:
All three TGF-betas demonstrated a marked mRNA overexpression in HCC in comparison with normal controls, whereas the levels of all three TGF-beta receptors showed no significant changes. Intense TGF-beta1, TGF-beta2, and TGF-beta3 immunostaining was found in hepatocellular carcinoma cells and in the perineoplastic stroma with immunohistochemistry, whereas no or mild immunostaining was present in the normal liver. For TbetaR-I ALK5 and TbetaR-II, the immunostaining in both HCC and normal liver was mild to moderate, with a slightly higher intensity in the normal tissues.
Conclusion:
The upregulation of TGF-betas in HCC suggests an important role for these isoforms in hepatic carcinogenesis and tumor progression. Moreover, the localization of the immunoreactivity in both malignant hepatocytes and stromal cells suggests that TGF-betas act via autocrine and paracrine pathways in this neoplasm.
Insights
Transforming growth factor betas (TGF-betas) are overexpressed in hepatocellular carcinoma (HCC), suggesting a key role in liver cancer development. These growth factors likely act through autocrine and paracrine pathways in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Transforming growth factor betas (TGF-betas) are polypeptides implicated in tumor growth.
- TGF-betas exert functions through cell surface receptors, including type I ALK5 and type II TGF-beta receptors.
- Hepatocellular carcinoma (HCC) is a significant global health concern.
Purpose of the Study:
- To investigate the expression and roles of TGF-betas and their signaling receptors in human HCC.
- To determine if TGF-beta signaling is altered in HCC compared to normal liver tissue.
Main Methods:
- Analysis of HCC and normal liver tissue samples from 18 HCC patients and 10 controls.
- Northern blot analysis to assess mRNA expression of TGF-beta1, -beta2, -beta3, and their receptors (TbetaR-I ALK5, TbetaR-II, TbetaR-III).
- Immunohistochemistry to localize the proteins of TGF-betas and their receptors.
Main Results:
- Significant mRNA overexpression of all three TGF-betas was observed in HCC tissues compared to normal liver.
- TGF-beta receptor levels (TbetaR-I ALK5, TbetaR-II, TbetaR-III) showed no significant changes between HCC and normal tissues.
- Intense TGF-beta1, -beta2, and -beta3 immunostaining was detected in HCC cells and stromal cells, with minimal staining in normal liver.
Conclusions:
- Upregulation of TGF-betas in HCC indicates a crucial role in hepatic carcinogenesis and tumor progression.
- The localization of TGF-beta immunoreactivity suggests autocrine and paracrine signaling mechanisms in HCC.
- Further research into TGF-beta pathways may offer therapeutic targets for liver cancer.